The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 11 August 2003 doi:10.1084/jem.20030788
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 186K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bottino, C.
Right arrow Articles by Moretta, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bottino, C.
Right arrow Articles by Moretta, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© Rockefeller University Press, 0022-1007/2003/8/557 $5.00
The Journal of Experimental Medicine, Volume 198, Number 4, 557-567

Identification of PVR (CD155) and Nectin-2 (CD112) as Cell Surface Ligands for the Human DNAM-1 (CD226) Activating Molecule

Cristina Bottino1, Roberta Castriconi2, Daniela Pende3, Paola Rivera2, Marina Nanni1,2, Barbara Carnemolla3, Claudia Cantoni1,2,4, Jessica Grassi2, Stefania Marcenaro1, Nicolas Reymond5, Massimo Vitale3, Lorenzo Moretta1,2,4, Marc Lopez5 and Alessandro Moretta2,4

1 Istituto Giannina Gaslini, 16148 Genova, Italy
2 Dipartimento di Medicina Sperimentale, Università di Genova, 16132 Genova, Italy
3 Istituto Nazionale per la Ricerca sul Cancro, 16132 Genova, Italy
4 Centro di Eccellenza per la Ricerca Biomedica, 16132 Genova, Italy
5 Institut de Biologie du Cancer et d'Immunologie, INSERM U.119, 13009 Marseille, France

Address correspondence to Alessandro Moretta M.D., Dipartimento di Medicina Sperimentale, Sezione di Istologia, Via G.B. Marsano 10, 16132 Genova, Italy. Phone: 39-010-35-37-868; Fax: 39-010-51-27-47; email: alemoret{at}unige.it

Human natural killer (NK) cells express a series of activating receptors and coreceptors that are involved in recognition and killing of target cells. In this study, in an attempt to identify the cellular ligands for such triggering surface molecules, mice were immunized with NK-susceptible target cells. On the basis of a functional screening, four mAbs were selected that induced a partial down-regulation of the NK-mediated cytotoxicity against the immunizing target cells. As revealed by biochemical analysis, three of such mAbs recognized molecules of ~70 kD. The other mAb reacted with two distinct molecules of ~65 and 60 kD, respectively. Protein purification followed by tryptic digestion and mass spectra analysis, allowed the identification of the 70 kD and the 65/60 kD molecules as PVR (CD155) and Nectin-2 {delta}/{alpha} (CD112), respectively. PVR-Fc and Nectin-2-Fc soluble hybrid molecules brightly stained COS-7 cells transfected with the DNAM-1 (CD226) construct, thus providing direct evidence that both PVR and Nectin-2 represent specific ligands for the DNAM-1 triggering receptor. Finally, the surface expression of PVR or Nectin-2 in cell transfectants resulted in DNAM-1–dependent enhancement of NK-mediated lysis of these target cells. This lysis was inhibited or even virtually abrogated upon mAb-mediated masking of DNAM-1 (on NK cells) or PVR or Nectin-2 ligands (on cell transfectants).

Key Words: natural killer cells • tumors • activating receptors • cellular ligands • protein sequencing


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS